Loading organizations...
§ Private Profile · South San Francisco, CA, USA
Phylo provides an integrated workspace with AI-assisted tools to support planning, execution, and review of biological research.
Phylo is an applied research lab dedicated to advancing biomedical science through the study of agentic intelligence. The organization's core mission is to accelerate the pace of scientific discovery for biomedical scientists globally by developing AI-assisted tools. These solutions are designed to support the planning, execution, and review phases of biological research, aiming to streamline complex tasks and provide insights.
The company is building "Biomni Lab," an integrated workspace intended to house its AI-powered solutions. Founded by two Stanford PhDs, Phylo emerged from stealth to introduce its AI agent technology for biomedical research.
Phylo has raised $148.5M across 2 funding rounds.
Phylo aims to accelerate discoveries for biomedical scientists by developing AI-assisted tools and studying agentic intelligence, which supports the planning, execution, and review of biological research.
Phylo aims to accelerate discoveries for biomedical scientists by developing AI-assisted tools and studying agentic intelligence, which supports the planning, execution, and review of biological research.
Phylo has raised $148.5M across 2 funding rounds. Most recently, it raised $135.0M Seed in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 9, 2026 | $135M Seed | Andreessen Horowitz, Menlo Ventures | Conviction, SV Angel, Zetta Venture Partners | Announced |
| Feb 3, 2026 | $13.5M Seed | Andreessen Horowitz, Anthology Fund | Conviction, SV Angel, Valkyrie, Zetta Venture Partners | Announced |
Phylo operates as an applied research lab with a primary focus on leveraging agentic intelligence to enhance biomedical research. The organization is committed to accelerating the pace of scientific discovery for biomedical scientists by developing advanced AI-assisted tools.
The lab's work centers on creating solutions that integrate into a comprehensive workspace, supporting various stages of biological research. These tools are designed to aid scientists in the planning, execution, and review processes of their investigations, aiming to improve efficiency and analytical capabilities.
Phylo's approach involves the study and application of agentic intelligence to develop sophisticated AI agents. These agents are engineered to assist researchers by streamlining complex tasks and providing data-driven insights, with the ultimate goal of fostering faster breakthroughs in the biomedical field.
The company is actively developing "Biomni Lab," which is envisioned as an integrated workspace. This platform is intended to serve as the central hub for the AI-powered solutions created by Phylo, offering a cohesive environment for scientific exploration and analysis.
Phylo was founded by two Stanford PhDs, who launched the company out of stealth to introduce their AI agent technology specifically tailored for biomedical research. The organization maintains its headquarters in South San Francisco, California.